Citizens JMP analyst Reni Benjamin upgraded Allogene Therapeutics (ALLO) to Outperform from Market Perform with a $5 price target The firm ...

Still, analysts expect Unity's revenue to be down 2% this year before growing 10% in 2026. If the new ad network and game ...

Citizens JMP downgraded Sutro Biopharma (STRO) to Market Perform from Outperform without a price target The firm cites the company’s ...

O n Monday, JMP Securities maintained its optimistic stance on AtriCure Inc. (NASDAQ:ATRC), reiterating a Market Outperform rating and a $60.00 price target. The firm's analysts highlighted their ...

Analysts expect the San Francisco, California-based company to report quarterly earnings at 85 cents per share, up from 76 ...

O n Monday, JMP Securities reaffirmed their Market Outperform rating on Xometry Inc (NASDAQ:XMTR) with a steady price target of $42.00. The company, currently trading at $35.67 with a market ...

Analysts expect the company to report quarterly earnings at $1.49 per share, up from $1.41 per share in the year-ago period.

Adobe (NASDAQ:ADBE – Free Report) had its price target lowered by KeyCorp from $450.00 to $390.00 in a research note published on Thursday,Benzinga reports. KeyCorp currently has an underweight rating ...

OppFi (NYSE:OPFI) shares dipped 4.9% in Wednesday midafternoon trading, adding to the prior trading session's retreat, after JMP analyst David ... valued at current prices. What's more, "we ...